Common Contracts
4 similar Collateral Agreement contracts by Aquestive Therapeutics, Inc., Egalet Corp, Vivus Inc
COLLATERAL AGREEMENT DATED AS OF NOVEMBER 1, 2023 AMONG AQUESTIVE THERAPEUTICS, INC., as Issuer, THE OTHER GRANTORS FROM TIME TO TIME PARTY HERETO, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee, and U.S. BANK TRUST COMPANY, NATIONAL...Collateral Agreement • November 2nd, 2023 • Aquestive Therapeutics, Inc. • Pharmaceutical preparations • New York
This COLLATERAL AGREEMENT is entered into as of November 1, 2023 (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this “Agreement”) by and among AQUESTIVE THERAPEUTICS, INC., a Delaware corporation (the “Issuer” and a Grantor as defined below), any other GRANTOR from time to time party hereto, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, in its capacity as trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
COLLATERAL AGREEMENT DATED AS OF JULY 15, 2019 AMONG AQUESTIVE THERAPEUTICS, INC., as Issuer, THE OTHER GRANTORS FROM TIME TO TIME PARTY HERETO, U.S. BANK NATIONAL ASSOCIATION, as Trustee, and U.S. BANK NATIONAL ASSOCIATION, as Collateral AgentCollateral Agreement • July 16th, 2019 • Aquestive Therapeutics, Inc. • Pharmaceutical preparations • New York
This COLLATERAL AGREEMENT is entered into as of July 15, 2019 (as more fully defined in Section 1.2 below, this “Agreement”) by and among AQUESTIVE THERAPEUTICS, INC., a Delaware corporation with an address at 30 Technology Drive, Warren, New Jersey 07059 (the “Issuer” and a Grantor as defined below), any other GRANTOR from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
COLLATERAL AGREEMENT DATED AS OF JANUARY 31, 2019 AMONG EGALET CORPORATION, as Issuer, EGALET US INC., EGALET LIMITED, THE SUBSIDIARY PARTIES FROM TIME TO TIME PARTY HERETO U.S. BANK NATIONAL ASSOCIATION, as Trustee, and U.S. BANK NATIONAL...Collateral Agreement • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • New York
THIS COLLATERAL AGREEMENT (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this “Agreement”) is entered into as of January 31, 2019, by and among EGALET CORPORATION, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the “Issuer”), EGALET US INC., a Delaware corporation (“Egalet US”), EGALET LIMITED, a private limited company formed under the law of England and Wales (“Egalet UK”), the other SUBSIDIARY PARTIES (as defined below) from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as Trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
COLLATERAL AGREEMENT DATED AS OF JUNE 8, 2018 AMONG VIVUS, INC., as Issuer, THE OTHER GRANTORS FROM TIME TO TIME PARTY HERETO,Collateral Agreement • June 11th, 2018 • Vivus Inc • Pharmaceutical preparations • New York
THIS COLLATERAL AGREEMENT (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this “Agreement”) is entered into as of June 8, 2018 by and among VIVUS, INC., a Delaware corporation, (the “Issuer”), any other GRANTOR (as defined below) from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
